7/13/2020 7:16:54 AM
Dewpoint Therapeutics Forges Exclusive Collaboration Agreement With Merck
7/8/2020 7:57:33 AM
Foghorn Therapeutics Enters Strategic Collaboration With Merck
7/8/2020 7:56:03 AM
Merck, Eisai Receive Complete Response Letter For KEYTRUDA Plus LENVIMA Combination
7/8/2020 7:54:29 AM
Merck And Eisai Receive CRL For KEYTRUDA Plus LENVIMA Combination
7/6/2020 6:57:13 AM
Merck Reports New Analyses Showing Addl. Safety, Efficacy Data For Islatravir Plus Doravirine
7/6/2020 1:10:48 AM
Ascentage Collaborates With MSD To Evaluate APG-115 In Combination With KEYTRUDA In Advanced Solid Tumors
6/22/2020 6:57:01 AM
Merck Says V114 Vaccine Meets Safety Objectives In Initial Phase 3 Studies In Adults
6/22/2020 6:54:54 AM
Merck's KEYTRUDA Approved By NMPA In China